title: Primary intraocular lymphoma: a review.
abstract: Primary intraocular lymphoma (PIOL) is a rare, non-Hodgkin lymphoma considered to be a subtype of primary central nervous system lymphoma. We describe a 65-year-old woman who presented to the Hematology/Oncology Clinic at Scripps Clinic, La Jolla, California, who was diagnosed with bilateral PIOL without systemic disease. She enjoyed a 16-month remission but ultimately recurred in the brain. We reviewed the literature and present a discussion of the diagnostic criteria for PIOL and current strategies for treating PIOL in immunocompetent patients.
authors.affiliation: Division of Hematology/Oncology, Scripps Clinic, 10666 N. Torrey Pines Road, La Jolla, CA 92037, USA. vosganian.gregory@scrippshealth.org
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Vosganian
authors.forename: Saskia
authors.initials: S
authors.lastname: Boisot
authors.forename: Kathrin I
authors.initials: KI
authors.lastname: Hartmann
authors.forename: William R
authors.initials: WR
authors.lastname: Freeman
authors.forename: Robert W
authors.initials: RW
authors.lastname: Sharpe
authors.forename: Prabhakar
authors.initials: P
authors.lastname: Tripuraneni
authors.forename: Alan
authors.initials: A
authors.lastname: Saven
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000556:secondary; D005134:Eye Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy; D011379:Prognosis; D012074:Remission Induction